| Literature DB >> 34580365 |
Masakazu Hamada1, Hiroaki Inaba2, Kyoko Nishiyama3, Sho Yoshida2, Yoshiaki Yura3, Michiyo Matsumoto-Nakano2, Narikazu Uzawa3.
Abstract
Autophagy-related genes (ARGs) have been implicated in the initiation and progression of malignant tumor promotion. To investigate the dynamics of expression of genes, including ARGs, head and neck squamous cell carcinoma (HNSCC) cells were placed under serum-free conditions to induce growth retardation and autophagy, and these starved cells were subjected to transcriptome analysis. Among the 21 starvation-induced genes (SIGs) located in the autophagy, cell proliferation, and survival signaling pathways, we identified SIGs that showed prominent up-regulation or down-regulation in vitro. These included AGR2, BST2, CALR, CD22, DDIT3, FOXA2, HSPA5, PIWIL4, PYCR1, SGK3, and TRIB3. The Cancer Genome Atlas (TCGA) database of HNSCC patients was used to examine the expression of up-regulated genes, and CALR, HSPA5, and TRIB3 were found to be highly expressed relative to solid normal tissue in cancer and the survival rate was reduced in patients with high expression. Protein-protein interaction analysis demonstrated the formation of a dense network of these genes. Cox regression analysis revealed that high expression of CALR, HSPA5, and TRIB3 was associated with poor prognosis in patients with TCGA-HNSCC. Therefore, these SIGs up-regulated under serum starvation may be molecular prognostic markers in HNSCC patients.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34580365 PMCID: PMC8476550 DOI: 10.1038/s41598-021-98544-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Univariate and multivariate analyses of three genes (CALR, HSPA5, and TRIB3) using the TCGA-HNSC patient data.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P-value | HR | 95%CI | P-value | |
| CALR_High(vs.Low) | 1.416 | 1.069–1.875 | – | |||
| HSPA5_High(vs.Low) | 1.362 | 1.029–1.804 | – | |||
| TRIB3_High(vs.Low) | 1.361 | 1.028–1.803 | – | |||
| Low–Low–Low | 1 | ref | 1 | ref | ||
| High–Low–Low | 1.208 | 0.607–2.405 | 0.590 | 1.455 | 0.696–3.043 | 0.319 |
| Low–High–Low | 1.326 | 0.805–2.186 | 0.268 | 1.398 | 0.833–2.348 | 0.205 |
| Low–Low–High | 0.733 | 0.290–1.850 | 0.510 | 0.691 | 0.245–1.949 | 0.485 |
| High–High–Low | 1.783 | 1.118–2.845 | 1.777 | 1.086–2.907 | ||
| High–Low–High | 1.901 | 1.002–3.608 | 1.805 | 0.934–3.488 | 0.079 | |
| Low–High–High | 1.861 | 1.061–3.265 | 1.887 | 1.021–3.486 | ||
| High–High–High | 1.619 | 1.088–2.410 | 1.614 | 1.056–2.467 | ||
| Age(per1year) | 1.016 | 1.003–1.029 | 1.023 | 1.009–1.038 | ||
| Sex_male(vs.female) | 0.721 | 0.535–0.973 | 0.862 | 0.611–1.215 | 0.396 | |
| HPVstatus_Positive(vs.Negative) | 0.777 | 0.524–1.153 | 0.210 | 0.784 | 0.505–1.218 | 0.279 |
| Alcohol_history_Yes(vs.No) | 0.947 | 0.701–1.279 | 0.723 | 1.051 | 0.75–1.472 | 0.774 |
| Cigarettesperday_>0(vs.0) | 0.960 | 0.724–1.272 | 0.774 | 0.963 | 0.709–1.309 | 0.811 |
| Mstage_m1(vs.m0) | 4.748 | 1.749–12.889 | 4.979 | 1.699–14.592 | ||
| Nstage(Continuousvariableper1) | 1.078 | 1.002–1.160 | 1.112 | 1.023–1.208 | ||
| n0 | 1 | ref | ||||
| n1 | 1.061 | 0.713–1.581 | 0.769 | |||
| n2 | 1.679 | 0.898–3.138 | 0.105 | |||
| n2a | 1.607 | 0.744–3.469 | 0.227 | |||
| n2b | 0.977 | 0.632–1.510 | 0.916 | |||
| n2c | 1.980 | 1.229–3.190 | ||||
| n3 | 1.698 | 0.623–4.624 | 0.300 | |||
| Tstage(Continuousvariableper1) | 0.999 | 0.902–1.106 | 0.986 | 0.979 | 0.877–1.092 | 0.700 |
| t1 | 1 | ref | ||||
| t2 | 1.092 | 0.57–2.092 | 0.790 | |||
| t3 | 1.421 | 0.746–2.705 | 0.285 | |||
| t4 | 1.543 | 0.681–3.496 | 0.299 | |||
| t4a | 1.056 | 0.554–2.015 | 0.868 | |||
| t4b | 1.984 | 0.439–8.960 | 0.373 | |||
HR: hazard ratio; 95% CI: 95% confidence interval; ref: reference value.
Figure 1Effects of serum starvation on the biological activity of HNSCC SAS cells. (A) Growth of SAS cells as measured by MTT assay after treatment for the indicated time, with or without serum. The data are shown as mean ± SD of 3 independent experiments and analyzed by t-test. (B,C) Migration assay in cells treated with/without serum. The bars show the area of scratches at 0 h. The rates of wound closure were determined from the assays and indicate the mean ± SD of 3 independent experiments. (D) The cell morphology was photographed with a phase contrast microscope. (E) TEM examination of SAS incubated for 24 h with/without serum. The bar markers represent 2 μm. M: mitochondria, AP: autophagosome, AL: autolysosome.
Expression of autophagy-related genes under serum starvation.
| ID | Description | NCBI gene ID | Fold change after 24 h | Fold change after 2 h |
|---|---|---|---|---|
| WIPI1 | WD repeat domain, phosphoinositide interacting 1 | 55,062 | 2.0886614 | 0.930744261 |
| XBP1 | X-box binding protein 1 | 7494 | 2.1410127 | 0.878980954 |
| NUPR1 | Nuclear protein 1, transcriptional regulator | 26,471 | 2.1501427 | 1.06686497 |
| NHLRC1 | NHL repeat containing E3 ubiquitin protein ligase 1 | 378,884 | 2.1578841 | 1.399708125 |
| ATP6V0A2 | ATPase H + transporting V0 subunit a2 | 23,545 | 2.3026843 | 1.142090599 |
| ATP6V1B1 | ATPase H + transporting V1 subunit B1 | 525 | 2.325067 | 0.828736747 |
| PIM2 | Pim-2 proto-oncogene, serine/threonine kinase | 11,040 | 2.378625 | 1.229401772 |
| TMEM150A | Transmembrane protein 150A | 129,303 | 2.6394634 | 1.155387955 |
| ATP6V1C2 | ATPase H + transporting V1 subunit C2 | 245,973 | 2.6718903 | 1.774302383 |
| ERN1 | endoplasmic reticulum to nucleus signaling 1 | 2081 | 2.9943194 | 1.146213323 |
| DDIT3 | DNA damage-inducible transcript 3 | 1649 | 3.1741931 | 0.597946814 |
| TRIB3 | Tribbles pseudokinase 3 | 57,761 | 3.8404264 | 0.991618344 |
| HMOX1 | Heme oxygenase 1 | 3162 | 0.49524766 | 0.945472836 |
| SRPX | Sushi repeat containing protein, X-linked | 8406 | 0.4878078 | 0.857148158 |
| RRAGD | Ras-related GTP-binding D | 58,528 | 0.4833195 | 0.845809254 |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 2597 | 0.4825641 | 0.94147729 |
| C10orf10 | Chromosome 10 open reading frame 10 | 11,067 | 0.46908534 | 1.273417327 |
| PLK2 | Polo-like kinase 2 | 10,769 | 0.40572378 | 0.835709592 |
| BNIP3L | BCL2-interacting protein 3-like | 665 | 0.37105525 | 0.898710392 |
| SESN3 | Sestrin 3 | 143,686 | 0.3578121 | 0.715624111 |
| DAPK2 | Death-associated protein kinase 2 | 23,604 | 0.34043416 | 0.718694176 |
| S100A9 | S100 calcium binding protein A9 | 6280 | 0.26209667 | 1.042621814 |
| MEFV | MEFV, pyrin innate immunity regulator | 4210 | 0.25515518 | 0.765465346 |
| S100A8 | S100 calcium binding protein A8 | 6279 | 0.24599823 | 1.095810293 |
| BNIP3 | BCL2-interacting protein 3 | 664 | 0.12660438 | 0.819784126 |
Genes that were selected by 6 keywords and showed high up-regulation or down-regulation under serum starvation.
| Key word | ID | Description | NCBI gene ID | Fold change after 24 h | Fold change after 2 h |
|---|---|---|---|---|---|
| Cell growth | HSPA1A | Heat shock protein family A (Hsp70) member 1A | 3303 | 2.1397336 | 1.248177638 |
| OSGIN1 | Oxidative stress-induced growth inhibitor 1 | 29,948 | 2.1668558 | 1.538782151 | |
| UCN | Urocortin | 7349 | 2.4790032 | 1.144155207 | |
| BST2 | Bone marrow stromal cell antigen 2 | 684 | 2.9329562 | 1.308922836 | |
| SGK3 | Serum/glucocorticoid regulated kinase family member 3 | 23,678 | 3.820176 | 1.176317287 | |
| EDN1 | Endothelin 1 | 1906 | 0.27418113 | 0.884857381 | |
| PSRC1 | Proline and serine rich coiled-coil 1 | 84,722 | 0.26818275 | 0.945457524 | |
| S100A9 | S100 calcium binding protein A9 | 6280 | 0.26209667 | 1.042621814 | |
| S100A8 | S100 calcium binding protein A8 | 6279 | 0.24599823 | 1.095810293 | |
| CDKN2C | Cyclin-dependent kinase inhibitor 2C | 1031 | 0.12124052 | 0.835693575 | |
| Cell death | LOC728739 | Programmed cell death 2 pseudogene | 728,739 | 2.3000002 | 1 |
| UCN | Urocortin | 7349 | 2.4790032 | 1.144155207 | |
| NPAS2 | Neuronal PAS domain protein 2 | 4862 | 2.689144 | 0.930857474 | |
| AGR2 | Anterior gradient 2, protein disulphide isomerase family member | 10,551 | 2.6983347 | 1.036070166 | |
| PYCR1 | Pyrroline-5-carboxylate reductase 1 | 5831 | 2.81048 | 1.165619558 | |
| GPR37L1 | G protein-coupled receptor 37 like 1 | 9283 | 0.3573708 | 0.929164088 | |
| AKR1C3 | Aldo–keto reductase family 1 member C3 | 8644 | 0.25129116 | 0.95490666 | |
| CTSV | Cathepsin V | 1515 | 0.24350072 | 0.872422377 | |
| BNIP3 | BCL2-interacting protein 3 | 664 | 0.12660438 | 0.819784126 | |
| AXIN2 | Axin 2 | 8313 | 0.07149426 | 0.979471303 | |
| Cell migration | BST2 | Bone marrow stromal cell antigen 2 | 684 | 2.9329562 | 1.308922836 |
| ADGRA2 | Adhesion G Protein-coupled receptor A2 | 25,960 | 3.3248994 | 1.09175771 | |
| CALR | Calreticulin | 811 | 3.6909635 | 0.82266943 | |
| SGK3 | serum/glucocorticoid regulated kinase family member 3 | 23,678 | 3.820176 | 1.176317287 | |
| HSPA5 | Heat shock protein family A (Hsp70) member 5 | 3309 | 7.4991713 | 0.83579081 | |
| STC1 | Stanniocalcin 1 | 6781 | 0.20706424 | 0.782881491 | |
| ANLN | Anillin actin binding protein | 54,443 | 0.18460144 | 0.933625648 | |
| TCAF2 | TRPM8 channel-associated factor 2 | 285,966 | 0.13127537 | 0.750317546 | |
| ATOH8 | atonal bHLH transcription factor 8 | 84,913 | 0.11830313 | 0.709818819 | |
| SERPINB3 | Serpin family B member 3 | 6317 | 0.11149136 | 1.039357318 | |
| Cell proliferation | SGK3 | Serum/glucocorticoid regulated kinase family member 3 | 23,678 | 3.820176 | 1.176317287 |
| IKZF3 | IKAROS family zinc finger 3 | 22,806 | 4.3976007 | 0.968962725 | |
| SPTA1 | Spectrin alpha, erythrocytic 1 | 6708 | 4.4961443 | 1.10674307 | |
| MIR17HG | miR-17-92a-1 cluster host gene | 407,975 | 4.602493 | 1.283155842 | |
| CD22 | CD22 molecule | 933 | 5.679524 | 1.044954641 | |
| ID2 | Inhibitor of DNA binding 2 | 3398 | 0.17407766 | 1.119070975 | |
| ATOH8 | Atonal bHLH transcription factor 8 | 84,913 | 0.11830313 | 0.709818819 | |
| SERPINB3 | Serpin family B member 3 | 6317 | 0.11149136 | 1.039357318 | |
| EGLN3 | Egl-9 family hypoxia inducible factor 3 | 112,399 | 0.100901835 | 0.74969137 | |
| AXIN2 | Axin 2 | 8313 | 0.07149426 | 0.979471303 | |
| Cell cycle | ERN1 | Endoplasmic reticulum to nucleus signaling 1 | 2081 | 2.9943194 | 1.146213323 |
| DDIT3 | DNA damage-inducible transcript 3 | 1649 | 3.1741931 | 0.597946814 | |
| BEX2 | Brain expressed X-linked 2 | 84,707 | 3.5948327 | 1.06210961 | |
| CALR | Calreticulin | 811 | 3.6909635 | 0.82266943 | |
| PIWIL4 | Piwi like RNA-mediated gene silencing 4 | 143,689 | 3.979958 | 1.182165243 | |
| CENPE | Centromere protein E | 1062 | 0.2240672 | 0.891558939 | |
| KCTD11 | Potassium channel tetramerization domain containing 11 | 147,040 | 0.20453872 | 0.83617986 | |
| MAP2K6 | Mitogen-activated protein kinase kinase 6 | 5608 | 0.19298029 | 0.761199796 | |
| ID2 | Inhibitor of DNA binding 2 | 3398 | 0.17407766 | 1.119070975 | |
| CDKN2C | Cyclin-dependent kinase inhibitor 2C | 1031 | 0.12124052 | 0.835693575 | |
| Cell adhesion | AMIGO1 | Adhesion molecule with Ig like domain 1 | 57,463 | 2.892857 | 1.089285831 |
| TNXB | Tenascin XB | 7148 | 3.0829856 | 1.187939406 | |
| TNC | Tenascin C | 3371 | 3.1931474 | 1.035432055 | |
| FOXA2 | Forkhead box A2 | 3170 | 3.3726099 | 0.838221697 | |
| CD22 | CD22 molecule | 933 | 5.679524 | 1.044954641 | |
| CXCL8 | C-X-C motif chemokine ligand 8 | 3576 | 0.3170054 | 0.587415932 | |
| SERPINI1 | Serpin family I member 1 | 5274 | 0.31145853 | 0.953841739 | |
| CDH2 | Cadherin 2 | 1000 | 0.29494244 | 1.09390035 | |
| CNTN1 | Contactin 1 | 1272 | 0.26283494 | 0.835311109 | |
| CCL2 | C–C motif chemokine ligand 2 | 6347 | 0.22852589 | 0.886680707 |
Figure 2Expression of serum starvation-induced genes (SIGs) in TCGA-HNSCC patients. The expression of 21 genes that showed significant changes in expression by serum starvation and their relative expression levels in TCGA-HNSCC patients were determined in primary tumors and solid normal tissues. (A) Box plots of the expression of 11 genes (AGR2, BST2, CALR, CD22, DDIT3, FOXA2, HSPA5, PIWIL4, PYCR1, SGK3, and TRIB3) that have been up-regulated more than two-fold. (B) Box plots of the expression of 10 genes (ATOH8, AXIN2, BNIP3, CCL2, CDKN2C, CNTN1, EGLN3, ID2, SERPINB3, and S100A8) that were down-regulated by more than 50%. * P < 0.05. (C) Heat map of 21 SIG expression profiles. Colors from blue to red indicate low to high expression levels.
Figure 3Function and protein–protein interaction analysis of SIGs. (A) A list of the top 8 significant GO terms determined by GO enrichment analysis of 21 selected genes. BP, biological process; CC, cellular composition; MF, molecular function. (B) List of molecular pathways determined by KEGG pathway enrichment analysis of 21 selected genes. (C) Proteins encoded by 21 genes extracted using 7 keywords were subjected to PPI network analysis. Up-regulated genes are shown in red. Down-regulation is shown in blue, and gray indicates genes whose expression did not change under serum starvation.
Figure 4Prognostic significance of SIGs in TCGA-HNSCC patients. Overall survival of TCGA-HNSCC patients, classified by 11 up-regulated SIG expression levels, was determined by the Kaplan–Meier method. The difference in survival time determined by the Kaplan–Meier method was examined using the generalized Wilcoxon test and the long rank test. (A) AGR2, (B) BST2, (C) CALR, (D) CD22, (E) DDIT3, (F) FOXA2, (G) HSPA5, (H) PIWIL4, (I) PYCR1, (J) SGK3, (K) TRIB3.
Figure 5Prognostic significance of combinational expression of CALR, HSPA5, and TRIB3 in TCGA-HNSCC patients. The survival curve was recalculated based on the expression of CALR, HSPA5, and TRIB3. (A) Survival curves for high CALR- high HSPA5 group, high CALR-low HSPA5 group, low CALR-high HSPA5 group, and low CALR-low HSPA5 group. (B) Survival curves for high CALR-high TRIB3 group, high CALR-low TRIB3 group, low CALR-high TRIB3 group, and low CALR-low TRIB3 group. (C) Survival curves for high HSPA5-high TRIB3 group, high HSPA5-low TRIB3 group, low HSPA5-high TRIB3 group, and low HSPA5-low TRIB3 group.